Advertisement
UK markets closed
  • FTSE 100

    8,164.12
    -15.56 (-0.19%)
     
  • FTSE 250

    20,286.03
    -45.77 (-0.23%)
     
  • AIM

    764.38
    -0.09 (-0.01%)
     
  • GBP/EUR

    1.1796
    -0.0009 (-0.07%)
     
  • GBP/USD

    1.2646
    +0.0005 (+0.04%)
     
  • Bitcoin GBP

    48,714.46
    +569.44 (+1.18%)
     
  • CMC Crypto 200

    1,280.22
    -3.61 (-0.28%)
     
  • S&P 500

    5,460.48
    -22.39 (-0.41%)
     
  • DOW

    39,118.86
    -45.24 (-0.12%)
     
  • CRUDE OIL

    81.46
    -0.28 (-0.34%)
     
  • GOLD FUTURES

    2,336.90
    +0.30 (+0.01%)
     
  • NIKKEI 225

    39,583.08
    +241.58 (+0.61%)
     
  • HANG SENG

    17,718.61
    +2.11 (+0.01%)
     
  • DAX

    18,235.45
    +24.85 (+0.14%)
     
  • CAC 40

    7,479.40
    -51.32 (-0.68%)
     

Exclusive-EU regulators likely to clear Novozymes, Chr. Hansen deal, sources say

A worker for the Danish biopharmaceutical company Novozymes stands next to fermentation vates for producing enzymes at a factory in Beijing

BRUSSELS (Reuters) - EU antitrust regulators are likely to clear the tie-up of Danish food ingredients and enzymes makers Novozymes and Chr. Hansen based on remedies offered to address competition concerns, two people with direct knowledge of the matter said on Wednesday.

Novozymes, which makes enzymes for household products, food and beverages and biofuels, and Chr. Hansen, an enzyme maker for the food sector, last month offered to sell part of the combined company's global lactase enzyme business, saying that a buyer had already been found.

(Reporting by Foo Yun Chee; Editing by Kirsten Donovan)